iDtheinvestordatabase
Home / Directory / HCV Management Viii
Activity not yet confirmed Verified 5 Nov 2026

HCV Management Viii

Cambridge, MA life science venture firm founded in 1985 that invests in pre-clinical and early clinical therapeutic, diagnostic and device companies, reporting $1.6 billion invested across 100+ companies.

Type
VC firm
Location
United States (Cambridge office)
Backs
Biotech and pharma, Medtech and digital health
Sectors
Healthtech and life sciences, Biotech
Fund size / AUM
$5.1M gross private fund assets (Form ADV; private funds: 2, of which venture capital: 2)

Contacts on file

For HCV Management Viii, the paid file holds: firm contact email (domain checked).

Get US Complete, $197 Free sample

One-time payment. No subscription. No account.

Sources

Last checked 5 Nov 2026. Is something wrong? Tell us.

Appears in 11 lists